Jula Inrig

Companies

• Travere Therapeutics, Inc.Chief Medical Officer Jan 4, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX100,491 shares²$5.3M at $53.15Sep 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Sold 400 shares at $65.31 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 1,600 shares at $63.69 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 17,284 shares at $62.62 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 25,390 shares at $62.02 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 32,395 shares at $8.93 of Travere Therapeutics, Inc.²
• Jun 22, 2026Gift 468 shares of Travere Therapeutics, Inc.³
• May 6, 2026Sold 311 shares at $43.95 of Travere Therapeutics, Inc.⁴
• May 5, 2026Sold 2,174 shares at $46.65 of Travere Therapeutics, Inc.⁴
• May 4, 2026Exercised options 4,250 shares of Travere Therapeutics, Inc.⁴
• May 4, 2026Sold 20,000 shares at $45.00 of Travere Therapeutics, Inc.⁴
• May 4, 2026Exercised options 20,000 shares at $22.40 of Travere Therapeutics, Inc.⁴
• Apr 15, 2026Sold 1,018 shares at $42.61 of Travere Therapeutics, Inc.⁵
• Apr 14, 2026Sold 7,215 shares at $41.93 of Travere Therapeutics, Inc.⁵
• Apr 13, 2026Granted 14,000 shares of Travere Therapeutics, Inc.⁵
• Feb 4, 2026Sold 232 shares at $32.85 of Travere Therapeutics, Inc.⁶
• Feb 4, 2026Sold 1,547 shares at $32.11 of Travere Therapeutics, Inc.⁶
• Feb 3, 2026Sold 6,956 shares at $32.12 of Travere Therapeutics, Inc.⁷
• Jan 31, 2026Granted 28,130 shares of Travere Therapeutics, Inc.⁷
• Jan 6, 2026Sold 445 shares at $37.75 of Travere Therapeutics, Inc.⁸
• Jan 5, 2026Sold 2,031 shares at $40.18 of Travere Therapeutics, Inc.⁸
• Dec 24, 2025Sold 15,000 shares at $42.00 of Travere Therapeutics, Inc.⁹
• Dec 24, 2025Exercised options 15,000 shares at $8.93 of Travere Therapeutics, Inc.⁹
• Jul 1, 2025Sold 815 shares at $14.65 of Travere Therapeutics, Inc.¹⁰
• Feb 12, 2025Sold 2,568 shares at $23.53 of Travere Therapeutics, Inc.¹¹
• Feb 10, 2025Exercised options 8,000 shares of Travere Therapeutics, Inc.¹¹